Guggenheim Capital LLC Puma Biotechnology, Inc. Transaction History

Guggenheim Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$20.07 - $46.7 $1.06 Million - $2.47 Million	-52,980 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$41.2 - $59.85 $164,429 - $238,861	3,991 Added 8.15%	52,980 $2.43 Million
Q2 2018 Aug 14, 2018	BUY	$48.3 - $68.25 $362,491 - $512,216	7,505 Added 18.09%	48,989 $2.9 Million
Q1 2018 May 15, 2018	BUY	$59.7 - $99.25 $319,932 - $531,880	5,359 Added 14.83%	41,484 $2.82 Million
Q4 2017 Feb 14, 2018	SELL	$93.85 - $132.45 $593,507 - $837,613	-6,324 Reduced 14.9%	36,125 $3.57 Million
Q3 2017 Nov 14, 2017	BUY	$72.0 - $119.75 $3.06 Million - $5.08 Million	42,449	42,449 $5.08 Million

101

29M

50.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $125M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Guggenheim Capital LLC with notifications on news.